Literature DB >> 21883666

Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study.

L Legout1, B Sarraz-Bournet, P V D'Elia, P Devos, A Pasquet, M Caillaux, F Wallet, Y Yazdanpanah, E Senneville, S Haulon, O Leroy.   

Abstract

Prosthetic vascular graft infection (PVGI) is a devastating complication, with a mortality rate of up to 75%, which is especially caused by aortic graft infection. The purpose of this study was to evaluate factors associated with in-hospital mortality of patients with definite graft infection, and with long-term outcome. We reviewed medical records of 85 patients treated for PVGIs defined by positive bacterial culture of intraoperative specimens or blood samples, and/or clinical, biological and radiological signs of infection. In-hospital patient mortality was defined as any death occurring during the initial treatment of the graft infection. Cure was defined as the absence of evidence of relapsing infection during long-term follow-up (≥1 year). Eighty-five patients (54 aortic and 31 limb graft infections) treated by surgical debridement and removal of the infected prosthesis (n=41), surgical debridement without removal of prosthesis (n=34) or antimicrobial treatment without surgery (n=10) were studied. The only microbiological difference observed between patients with early (occurring within 4 months after surgery) vs. late PVGI and between those with aortic vs. limb PVGI was the incidence of PVGI caused by Staphylococcus aureus, which was greater in patients with limb PVGI. Overall cure was observed in 93.2% of 59 patients with a follow-up of a minimum of 1 year. Overall in-hospital mortality was 16.5% (n=14). Two variables were independently associated with mortality: age >70 years (OR 9.1, 95% CI 1.83-45.43, p 0.007) and aortic graft infection (OR 5.6, 95% CI 1.1-28.7, p 0.037).
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21883666     DOI: 10.1111/j.1469-0691.2011.03618.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  23 in total

1.  Cutaneous septic embolism presenting as erythematous plaques.

Authors:  Javier Galve; Priscila Giavedoni; Llúcia Alós; Mercè Alsina-Gibert
Journal:  Ann Dermatol       Date:  2013-08-13       Impact factor: 1.444

2.  The role of FDG PET/CT in therapy control of aortic graft infection.

Authors:  Lars Husmann; Bruno Ledergerber; Alexia Anagnostopoulos; Paul Stolzmann; Bert-Ram Sah; Irene A Burger; Roxana Pop; Alberto Weber; Dieter Mayer; Zoran Rancic; Barbara Hasse
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-06-11       Impact factor: 9.236

3.  Bio-absorbable antibiotic impregnated beads for the treatment of prosthetic vascular graft infections.

Authors:  Elizabeth A Genovese; Efthymios D Avgerinos; Donald T Baril; Michel S Makaroun; Rabih A Chaer
Journal:  Vascular       Date:  2016-02-18       Impact factor: 1.285

4.  Surgical and medical interventions for abdominal aortic graft infections.

Authors:  Osamah S Niaz; Ahsan Rao; Ahmed Abidia; Rebecca Parrott; Jonathan Refson; Pranav Somaiya
Journal:  Cochrane Database Syst Rev       Date:  2020-08-05

5.  Radiolabelled leucocyte scintigraphy versus conventional radiological imaging for the management of late, low-grade vascular prosthesis infections.

Authors:  P A Erba; G Leo; M Sollini; C Tascini; R Boni; R N Berchiolli; F Menichetti; M Ferrari; E Lazzeri; G Mariani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-19       Impact factor: 9.236

6.  Laparoscopic pancreaticoduodenectomy with reconstruction of the mesentericoportal vein with the parietal peritoneum and the falciform ligament.

Authors:  Safi Dokmak; Béatrice Aussilhou; Mélanie Calmels; Houcine Maghrebi; Fadhel Samir Ftériche; Olivier Soubrane; Alain Sauvanet
Journal:  Surg Endosc       Date:  2018-01-18       Impact factor: 4.584

7.  Culture Negative Stent Infection in an Infant with Hypoplastic Left Heart and Persistent Fever.

Authors:  Kurt D Piggott; Federico Laham; Alejandro Jordan Villegas; Harun Fakioglu; Carlos Blanco; Sukumar Suguna Narasimhulu
Journal:  Case Rep Cardiol       Date:  2015-09-08

8.  SarA based novel therapeutic candidate against Staphylococcus aureus associated with vascular graft infections.

Authors:  Rekha Arya; R Ravikumar; R S Santhosh; S Adline Princy
Journal:  Front Microbiol       Date:  2015-05-06       Impact factor: 5.640

9.  Factors predictive of treatment failure in staphylococcal prosthetic vascular graft infections: a prospective observational cohort study: impact of rifampin.

Authors:  Laurence Legout; Piervito Delia; Béatrice Sarraz-Bournet; Cécile Rouyer; Massongo Massongo; Michel Valette; Olivier Leroy; Stephan Haulon; Eric Senneville
Journal:  BMC Infect Dis       Date:  2014-04-28       Impact factor: 3.090

10.  Open wounds and rifampicin therapy are associated with rifampicin resistance among staphylococcal vascular graft/endograft infections.

Authors:  Yau Kei Stefan Leung; Bruno Ledergerber; Nadia Eberhard; Carlos A Mestres; Zoran Rancic; Alexander Zimmermann; Reinhard Zbinden; Silvio D Brugger; Annelies S Zinkernagel; Barbara Hasse
Journal:  JAC Antimicrob Resist       Date:  2021-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.